MMYT vs. MLTX
Compare and contrast key facts about MakeMyTrip Limited (MMYT) and MoonLake Immunotherapeutics (MLTX).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: MMYT or MLTX.
Performance
MMYT vs. MLTX - Performance Comparison
Returns By Period
In the year-to-date period, MMYT achieves a 133.48% return, which is significantly higher than MLTX's -14.12% return.
MMYT
133.48%
6.51%
46.94%
158.34%
34.08%
14.27%
MLTX
-14.12%
8.04%
29.78%
14.46%
N/A
N/A
Fundamentals
| MMYT | MLTX | |
|---|---|---|
| Market Cap | $11.78B | $3.14B |
| EPS | $1.90 | -$1.27 |
| Total Revenue (TTM) | $882.62M | $39.48K |
| Gross Profit (TTM) | $491.36M | -$34.48K |
| EBITDA (TTM) | $158.93M | -$108.45M |
Key characteristics
| MMYT | MLTX | |
|---|---|---|
| Sharpe Ratio | 3.11 | 0.41 |
| Sortino Ratio | 3.28 | 0.93 |
| Omega Ratio | 1.45 | 1.11 |
| Calmar Ratio | 7.48 | 0.53 |
| Martin Ratio | 22.01 | 0.84 |
| Ulcer Index | 7.20% | 24.94% |
| Daily Std Dev | 51.00% | 50.87% |
| Max Drawdown | -73.45% | -64.60% |
| Current Drawdown | -3.31% | -18.79% |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Correlation
The correlation between MMYT and MLTX is 0.08, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Risk-Adjusted Performance
MMYT vs. MLTX - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for MakeMyTrip Limited (MMYT) and MoonLake Immunotherapeutics (MLTX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
MMYT vs. MLTX - Dividend Comparison
Neither MMYT nor MLTX has paid dividends to shareholders.
Drawdowns
MMYT vs. MLTX - Drawdown Comparison
The maximum MMYT drawdown since its inception was -73.45%, which is greater than MLTX's maximum drawdown of -64.60%. Use the drawdown chart below to compare losses from any high point for MMYT and MLTX. For additional features, visit the drawdowns tool.
Volatility
MMYT vs. MLTX - Volatility Comparison
MakeMyTrip Limited (MMYT) has a higher volatility of 18.11% compared to MoonLake Immunotherapeutics (MLTX) at 14.53%. This indicates that MMYT's price experiences larger fluctuations and is considered to be riskier than MLTX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
MMYT vs. MLTX - Financials Comparison
This section allows you to compare key financial metrics between MakeMyTrip Limited and MoonLake Immunotherapeutics. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities